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Transplantation of dopaminergic (DA) neurons is considered to be the most promising
herapeutic strategy for replacing degenerated dopamine cells in the midbrain of
arkinson’s disease (PD), thereby restoring normal neural circuit function and slow
linical progression of the disease. Human neural stem cells (hNSCs) derived from fetal
orebrain are thought to be the important cell sources for producing DA neurons because
f their multipotency for differentiation and long-term expansion property in cultures.
owever, low DA differentiation of the forebrain-derived hNSCs limited their therapeutic
otential in PD. In the current study, we explored a combined application of Pramipexole
PRX), bone morphogenetic proteins 7 (BMP-7), and growth factors, including acidic
broblast factor (aFGF), forskolin, and phorbol-12-myristae-13-acetate (TPA), to induce
ifferentiation of forebrain-derived hNSCs toward DA neurons in cultures. We found
hat DA neuron-associated genes, including Nurr1, Neurogenin2 (Ngn2), and tyrosine
ydroxylase (TH) were significantly increased after 24 h of differentiation by RT-PCR
nalysis (p < 0.01). Fluorescent examination showed that about 25% of cells became
H-positive neurons at 24 h, about 5% of cells became VMAT2 (vascular monoamine
ransporter 2)-positive neurons, and less than 5% of cells became DAT (dopamine
ransporter)-positive neurons at 72 h following differentiation in cultures. Importantly,
hese TH-, VMAT2-, and DAT-expressing neurons were able to release dopamine into
ultures under both of the basal and evoked conditions. Dopamine levels released by DA
eurons produced using our protocol were significantly higher compared to the control
roups (P< 0.01), as examined by ELISA. Our results demonstrated that the combination
f PRX, BMP-7, and growth factors was able to greatly promote differentiation of the
orebrain-derived hNSCs into DA-releasing neurons.
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INTRODUCTION
Parkinson disease (PD) as one of the most common
neurodegenerative diseases is characterized by marked
depletion of dopamine caused by dopaminergic neurons
loss or degeneration in substantia nigra (SN) of the midbrain.
To date, PD is still considered to be incurable and irreversible
to the disabilities although the levodopa replacement therapy
significantly remits the symptoms (Suzuki et al., 2015). Cell
replacement therapy for PD, especially dopaminergic (DA)
neurons, is considered to be the most promising candidate
for restoring nigrostriatal DA transmission in the treatment
of PD, Embryonic stem cells (ESCs) have been successfully
induced to differentiate into DA neurons in vitro using various
protocols (Kirkeby et al., 2012; Yang et al., 2014; Lim et al., 2015).
However, many problems in ESCs, including their propensity
to form teratomas and ethical issues, limit their clinical uses
(Christophersen et al., 2006; Knoepfler, 2009). Although specific
DA neuron-associated gene overexpression in midbrain-derived
NSCs resulted from experimental gene transfection technology
could produce DA neurons in vitro (Andersson et al., 2007),
there is a safety concern for clinical uses of such gene-transfected
cells. Midbrain-derived hNSCs may be more intended to
differentiate into DA neurons, however, clinical application has
been hindered due to the lack of sufficient midbrain tissues. In
addition, midbrain-derived hNSCs will lose their proliferative
property and multipotency for differentiation in long term
cultures (Christophersen et al., 2006). Human neural stem cells
(hNSCs) have been successfully isolated from fetal forebrains
and these forebrain-derived hNSCs can be expanded in cultures
for more than a year without losing their multipotency to
differentiate into neurons and glial cells (Christophersen et al.,
2006). Thus, forebrain-derived hNSCs can serve as suitable cell
sources to provide sufficient number of candidate cells and to
differentiate into DA neurons for transplantation uses in PD.
More importantly, forebrain-derived hNSCs do not intend to
form tumors when used for transplantation (Daadi et al., 2012).
However, forebrain-derived hNSCs appear to hardly differentiate
into functional DA neurons, lacking the capacity to release
dopamine, compared to midbrain-derived hNSCs, which limited
their therapeutic application in PD.
Nurr1, known as a member of the nuclear receptor family,
is not only essential for the development of mesencephalic
DA neurons but also a regulatory factor of differentiation,
migration, and maturation of mesencephalic DA neurons
(Li et al., 2011). Nurr1 is also involved in establishing the
DA neurotransmitter identity of DA neurons in cultured
cells, including ES cells, primary neural precursors derived
from forebrain cortex, midbrain, and developing striatum.
However, over-expression of Nurr1 alone is not sufficient to
induce the expression of additional markers of DA neurons
except for tyrosine hydroxylase (TH) (Andersson et al., 2007).
Neurogenin2 (Ngn2) is proved to be critical for DA neuron
differentiation of mesencephalic progenitors (Thompson et al.,
2006). Over-expression of Ngn2 alone in midbrain-derived
progenitors is not sufficient either to result in DA neurons
except for neuronal maturation (Andersson et al., 2007).
However, it has been reported that progenitors derived from
fetal mouse ventral midbrain can further develop into neuronal
cells expressing not only TH but also additional DA neuron
markers, such as vascular monoamine transporter (VMAT2),
by over-expression of gene Nurr1 and Ngn2 (Andersson et al.,
2007). Although TH-expressing neurons can be induced from
forebrain progenitors using growth factors, the percentage of
these TH-expressing neurons is low (4–10%) and other DA
neuron markers cannot be detected in these differentiated cells
(Christophersen et al., 2006).
Pramipexole (PRX), as a non-ergot DA D2/D3 receptor
agonist, is attracting more and more attention because of its
effect on the treatment of early as well as advanced PD. In vivo
experiments showed that PRX can can promote DA neurogenesis
and increase motor activity in a PD animal model (Winner
et al., 2009). In vitro experiments demonstrated that PRX can
significantly induce the expression of DA neuron-associated
genes [Nurr1, DAT (dopamine transporter), and VMAT2] in
SH-SY5Y cells (Pan et al., 2005). Bone morphogenetic proteins
7 (BMP-7), as one of the transforming growth factor β (TGF-β)
family members, has been proven to increase the number of
TH-positive cells and dopamine uptake of rat mesencephalic
cells in vitro (Lee et al., 2003). Its application can also
significantly decrease DA neurons loss caused by 6-OHDA
(6-hydroxydopamine) in vivo (Harvey et al., 2004). In addition,
BMP-7 is able to up-regulate and maintain the expression of
Ngn2 (Segklia et al., 2012).
Because BMP7 and PRX can upregulate the expression of
DA neuron-associated key genes Nurr1 and Ngn2, and growth
factors including acidic fibroblast factor (aFGF), forskolin, and
phorbol-12-myristae-13-acetate (TPA), have been confirmed
in previous studies to enhance the expression of TH in
forebrain-derived hNSCs (Christophersen et al., 2006), we
explored the possibility in the current studies to promote the
differentiation of forebrain-derived hNSCs into DA-producing
neurons by a combined application of PRX and BMP-7 with these
growth factors.
METHODS AND MATERIALS
Culture of hNSCs (Human Neural Stem
Cells)
hNSCs were purchased from Lonza (Walkersville, MD, USA).
The detailed methods for the growth and maintenance of
undifferentiated hNSCs were conducted according to the
protocol we previously published (Ma et al., 2011). In
brief, hNSCs were cultured in T-75 flask containing 15 ml
complete culture medium including DMEM/F12 (Invitrogen,
CA, USA), human recombinant epidermal growth factor (EGF;
20 ng/ml) and basic fibroblast growth factor (bFGF; 20 ng/ml)
(R&D Systems, Minneapolis, MN, USA), B27 (serum-free
medium supplements formulated to provide optimal growth
condition for NSC expansion, 1:50; Invitrogen), heparin
(5µg/ml; Sigma, St Louis, MO, USA), 2mM L-glutamine, and
an antibiotic–antimycotic mixture (1: 100; Invitrogen) at 37◦C
in a 5% CO2 humidified incubation chamber (Fisher, Pittsburgh,
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PA, USA). 7.5ml fresh complete culture medium was changed
every 3 days. Every 1–2 week, we cut the larger neuro-spheroids
into small spheroids under the observation of the microscope
(Olympus, Japan).
Induction of Dopaminergic Differentiation
hNSC spheres were mechanically dissociated into small spheres,
part of which were plated on 12mm (diameter) glass coverslips
coated with poly-l-lysine in 1ml complete culture medium
supplemented with 1% fetal bovine serum (FBS) for promoting
cell attaching to the coverslips. Other spheres were further
prepared into single cells using accutase (Chemicon) and 1 ×
106 of single cells were plated in the 50mm (diameter) tissues
culture dishes in 4ml complete culture medium supplemented
with 1% FBS overnight for PCR and dopamine release analysis.
On the second day, the medium were completely discharged and
replaced with the same volume of differentiated medium, which
included B27 medium supplemented with 1% FBS, BMP-7 (bone
morphogenetic proteins, Peprotech, 50 ng/ml), pramipexole
(PRX, Sigma, 10 ìm), and growth factors, including acidic
fibroblast factors (aFGF, Sigma, 100 ng/ml), forskolin (Sigma, 25
ìm), and phorbol-12-myristae-13-acetate (TPA, Sigma, 100 nm).
The controls were divided into two groups: one was cultured in
B27 medium supplemented with 1% FBS and growth factors, the
other was cultured in B27 medium supplemented with 1% FBS.
RT-PCR
For PCR analysis, the cells were cultured in vitro for 24 h.
Total RNA was extracted with Trizol (Invitrogen) following
the manufacturer’s protocol. One microgram of total RNA
was used for reverse transcription using ImProm-IITM Reverse
Transcription System (Promega) in a total volume of 20µl.
cDNA from all samples was synthesized at the same time
using the same master mix to avoid variations. All PCRs were
performed by using Quick-Load R© Taq Master Mix (NEB) with
2µl cDNA and final concentration of primer at 0.5µM. The final
reaction volume of PCR was 20µl. All reactions were performed
in triplicate. β-actin was used as internal control for equal loading
of cDNA. PCR products were separated on 1.5% agarose gel, and
quantified by densitometric analysis with quantity one system
(Bio-Rad, USA). Data was from four independent experiments.
The primers used in the research were listed as follows: β-actin:
F (forward): 5′-GAA GTC CCT TGC CAT CCT AAA-3′; R
(Reverse): 5′-GTC TCA AGT CAG TGT ACA GGT AAG-3′;
Nurr1: F: 5′-GAA CTG CAC TTG GGC AGA GTT G-3′; R: 5′-
GGT GGA CAG TGT CGT AAT TC-3′; Ngn2: F: 5′-GGT CTG
GTACACGATTGCAAAC-3′; R: 5′-GCTGTTGGTGCAACT
CCA CGT-3′; TH: F: 5′-TGT CCA CGC TGT ACT GGT TC-3′;
R: 5′-AGC TCC TGA GCT TGT CCT TG-3′.
Immunocytochemistry
After induction in vitro for 24 and 72 h, respectively, the
differentiated cells were fixed in 4% paraformaldehyde (PFA) in
phosphate buffered saline (PBS) for 20min at room temperature
(RT). The cells were washed three times with PBS, followed by
overnight incubation with primary antibodies diluted in PBS
containing 5% normal donkey serum (Jackson Immunoresearch
Laboratories), 0.1% Triton X-100 at 4◦C in a humidified
chamber. On the second day, the cells were washed three
times with PBS and incubated for 1 h at room temperature
in the dark with secondary antibodies diluted in PBS. After
washing three times with PBS, the cells were cover slipped with
medium for fluorescence with DAPI (Vector Labs) and viewed
by fluorescence microscopy (Olympus, Japan). The primary
antibodies used were: mouse anti-β-tubulin III (Sigma 1:400);
rabbit anti-TH (PelFreez 1:200); rabbit anti-DAT (Millipore
1:400), and rabbit anti-VMAT2 (Santa cruz 1:100). The
secondary antibodies used in these experiments were: anti-mouse
TRITC and anti-rabbit FITC (all from Jackson Immunoresearch
Laboratories). In order to quantify the percentage of TH-, DAT-,
or VMAT2-immunopositive cells out of the total cell population,
cells were counted at 200 × magnification, three fields were
randomly chosen in each culture and the percentage of TH-,
DAT-, or VMAT2-immunopositive cells was calculated with
respect to the total number of cells indicated by DAPI-positive
nuclei. Data are from four independent experiments. On average,
400 cells were examined in each experiment.
Dopamine Release
Dopamine release was quantified using ELISA kits (Dopamine
Research EIA, LaborDiagnostika Nord GmbH & Co. KG,
German) analyses after 3 days of differentiation in vitro.
Every group was divided into two subgroups. Subgroup1 was
incubated in 1.5ml HBSS for 15min to test basal dopamine
release. Subgroup2 was incubated in 1.5ml HBSS plus 56mM
KCl for 15min to measure evoked dopamine release. All
samples were stabilized immediately with orthophosphoric
acid (7.5%)/metabisulfate (0.22mg/ml) and stored at −80◦C
before analysis. Dopamine extraction, acylation, and enzyme
immunoassay were performed according to the manufacturers’
instructions. Every sample and standard was performed in
duplicated. Absorbance was read using a microplate reader set to
450 nm and a reference wavelength set between 620 and 650 nm.
Data were from four independent experiments.
Statistical Analysis
Data were expressed as the mean ± SD. SPSS 16.0 was used to
perform the statistical analysis. One-factor ANOVA was used to
assess statistical significance between the means. The statistical
significance was established at P < 0.05 (∗p< 0.05, ∗∗p< 0.01).
RESULTS
Our New Defined Culture Condition
Significantly Increased the Expression of
DA Neuron-Associated Genes in the
Differentiated Forebrain-Derived hNSCs
To examine whether our new defined culture condition has
any biological effect on DA neuron-associated genes, RT-PCR
was performed to measure the expression of Nurr1, Ngn2, and
TH genes in the forebrain-derived hNSCs at 24 h after in vitro
differentiation. As illustrated in Figures 1A–D, the expression of
these DA neuron-associated genes were significantly augmented
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FIGURE 1 | The combined application of BMP-7, pramipexole, and
growth factors in culture significantly increased the expression of DA
neuron-associated genes of forebrain-derived hNSCs. (A) Gene
expression of Nurr1, Ngn2, and TH examined by RT-PCR at 24 h of
differentiation. Forebrain-derived hNSCs were treated with 1% FBS, 1% FBS
and growth factors, and 1% FBS, BMP-7, pramipexole, and growth factors,
respectively. (B–D) Bar graphs showing that the gene expression of Nurr1,
Ngn2, and TH was significantly improved by the combined application of
BMP-7, pramipexole, and growth factors in cultures compared to controls.
Human β-actin gene fragment was used for internal control. All experiments
were performed with four independent cDNAs. PCR products were analyzed
by electrophoresis in 1.5% agarose gel containing ethidium bromide and
quantified by densitometric analysis with quantity one system. Data were
presented as mean ± S.E.M. One-factor ANOVA was used to assess
statistical significance between means (**P < 0.01).
under our new defined culture condition compared to control
groups (p< 0.01).
TH-, VMAT2-, and DAT-Positive Cells were
Significantly Increased under our New
Defined Culture Condition
After 24 and 72 h of differentiation, fluorescent
immunocytochemistry was conducted to examine TH-,
DAT-, and VMAT2-positive neurons in differentiated forebrain
hNSCs. As shown in Figures 2A–C, 3A, our defined culture
condition significantly increased the number of TH-positive
cells in the culture after 24 h of differentiation compared to
control groups. In addition, these TH-positive neurons possessed
longer neuronal processes or fibers than those in control groups
(Figures 2A–C). However, VMAT2- and DAT-positive cells
were not detected at 24 h until at 72 h after differentiation
using our new defined culture condition. VMAT2-positive cells
occupied about 5%, and DAT-positive cells occupied less than
5% of the total population of the neuronal cells in the culture
(Figures 2D,E). Most of the TH-positive cells, DAT-positive cells,
and VMAT2-positive cells co-expressed β-tubulin III, the marker
for neurons. In control groups, no DAT- or VMAT2-positive
cells were detected at either 24 or 72 h of differentiation.
The Levels of Dopamine Release by the
Differentiated Da Neurons were
Significantly Increased at Basal and
Evoked Conditions in our New Defined
Culture System
To confirm whether the differentiated DA neurons from
forebrain hNSCs are functional and release dopamines in
cultures, the basal, and evoked levels of dopamine releases by
these cells were respectively assessed with ELISA. As shown in
Figures 3B,C, not only the basal levels but also the evoked levels
of dopamine release were significantly increased compared to
those in control groups. Thus, these DA neurons differentiated
from forebrain-derived hNSCs in our defined culture system
were DA-producing neurons and may serve as suitable cell
sources for PD treatment.
DISCUSSION
hNSCs derived from forebrain can be expanded for long time
as free-floating neurospheres and differentiated into neurons,
astrocytes and oligodendrocytes. Thus, we can get plenty of
hNSCs by in vitro culture without losing their multipentcy.
However, the low efficiency to generate functional dopamine
neurons from forebrain-derived hNSCs limited their therapeutic
potential as the donor cells. In the current study, we used a new
culture condition, supplemented with PRX, BMP-7, and growth
factors, to differentiate more DA neurons from the forebrain-
derived hNSCs. We generated DA neurons with the expression
of both TH and VMAT2, and these DA neurons were confirmed
to release dopamine in cultures.
PRX is known to induce the expression of Nurr1 in SH-
SY5Y cells. BMP-7 is confirmed to not only be involved in the
expression of Ngn2 in mouse cortex neurons but also maintain
the steady-state levels of Ngn2 transcripts in the developmental
window between E14-15 (Segklia et al., 2012). As expected, both
gene expression of Nurr1 and Ngn2 in differentiated hNSCs
of forebrain origin were induced and augmented significantly
using our defined culture condition compared to those in control
groups (Figures 1A–C). Nurr1, an orphan nuclear receptor, is
crucial for DA differentiation andmaintenance, usually expressed
in post-mitotic DA neuroblasts prior to TH expression. The
expression of TH was also successfully induced after 24 h
of differentiation under our new defined culture condition
(Figure 1A). Our results suggest that the expression of Nurr1
may climb the steady peak before 24 h of differentiation, the Ngn2
may promote hNSCs to differentiate towardmature neurons, and
over-expression of Nurr1 andNgn2 in combinationmay generate
morphologically mature TH- expressing neurons (Andersson
et al., 2007). Consistent with the experimental data obtained from
mesencephalic progenitors, TH- expressing neurons produced
under our new defined culture condition have longer neuronal
processes and fibers (Figures 2A–C).
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FIGURE 2 | TH-, VMAT2-, and DAT-positive cells were detected in the cultures with the combined application of BMP-7, pramipexole, and growth
factors. (A–C) TH-positive neurons in (A) 1% FBS, (B) 1% FBS and growth factors, and (C): 1% FBS, BMP-7, pramipexole, and growth factors examined by
fluorescent immunocytochemistry examined at 24 h of differentiation. Green: TH-positive cells, Red: β-tubulin III-positive cells, Blue: DAPI labeled nuclei, Yellow:
co-localization of TH (green) and β-tubulin III (red) in the same cells. Bar = 200µm. (D) VMAT2-positive neurons in cultures with 1% FBS, BMP-7, pramipexole, and
growth factors examined at 72 h of differentiation by fluorescent immunocytochemistry. Green: VMAT-2-positive cells, Red: β-tubulin III-positive cells, Blue: DAPI
labeled nuclei, Yellow: co-localization of TH (green) and β-tubulin III (red) in the same cells. No VMAT2-positive neurons were detected in cultures of the controls. Bar =
100µm. (E) DAT-positive neurons in cultures with 1% FBS, BMP-7, pramipexole, and growth factors examined at 72 h of differentiation by fluorescent
immunocytochemistry. Green: DAT-positive cells, Red: β-tubulin III-positive cells, Blue: DAPI labeled nuclei, Yellow: co-localization of DAT (green) and β-tubulin III (red)
in the same cells. No DAT-positive neurons were detected in cultures of the controls. Bar = 100µm.
FIGURE 3 | Dopamine release was significantly increased at both basal and evoked levels in DA neurons produced in cultures containing 1% FBS,
BMP-7, pramipexole, and growth factors. (A) Bar graphs showing that the number of DA neurons produced in cultures containing 1% FBS, BMP-7, pramipexole,
and growth factors were significantly increased compared to controls. (B,C) The basal (B) and evoked (C) levels of dopamine released by DA neurons were
significantly augmented in cultures containing 1% FBS, BMP-7, pramipexole, and growth factors compared to those in cultures of the controls. Data were received
with four independent experiments. Basal or evoked dopamine releases were assessed by ELISA. Data were presented as mean ± S.E.M. One-factor ANOVA was
used to assess statistical significance between means (**P < 0.01, *P < 0.05).
TH is the enzyme that catalyzes the initial, rate-limiting step in
the biosynthesis of catecholamines, including DA, noradrenaline,
and adrenaline. Expression of TH alone is not sufficient to
prove that the neurons are dopaminergic. VMAT2 is responsible
for packaging newly synthesized or recaptured DA into the
synaptic vesicles, and therefore controls the concentration and
disposition of cytoplasmic DA within the nerve terminal. Thus,
VMAT2 is a marker for mature and functional DA neurons. We
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did not find VMAT2-positive neurons at 24 h of differentiation
but at 72 h of differentiation using our new defined culture
condition (Figure 2D). DAT, as another marker for mature
and functional DA neurons, plays a key role in terminating
dopaminergic signaling and in maintaining a releasable pool of
dopamine (German et al., 2015). DAT-positive neurons at 24 h
of differentiation were not detected until at 72 h of differentiation
by using our culture condition (Figure 2E). These data suggest
that our new defined culture condition may have efficiently
generated mature and functional DA neurons from forebrain-
derived hNSCs. However, further studies are needed to assess the
efficiency of the proposed protocol for long term differentiation
of DA neurons, since the degree of DA differentiation showed
after 72 h is quite limited.
The most important physiological aspect of functional
DA neurons is the ability to synthesize and release DA
neurotransmitter in response to membrane depolarization.
In the current studies, ELISA was used to test the basal
(DA neurotransmitter at resting status) and evoked (DA
neurotransmitter release by responding to cell membrane
depolarization) DA neurotransmitter release. As shown in
Figures 3B,C, DA neurons produced by our protocol not only
have the capability to synthesize DA but also release DA in
response to membrane depolarization evoked by KCl than those
obtained in control groups. Collectively, our results showed that
the combined application of PRX and BMP-7 with growth factors
in culture greatly promote the production of more DA-releasing
neurons from forebrain-derived hNSCs.
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